# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Avian influenza continues to spread among animals and has infected four dairy workers in the US. Concerns about human-to-human ...
The funds are intended to launch a series of new biotech companies that will harness the power of generative artificial intelli...
Moderna and Mitsubishi signed a joint agreement regarding the co-promotion of Moderna's respiratory vaccine portfolio in Ja...
Under the agreement, Moderna will handle the manufacturing, sales, medical education and distribution of its mRNA respiratory v...
Word to the wise: Ed Yardeni, in a July 4 note, warns his clients: "Too much capital can end even the best of parties."
Moderna announced a $176 million award for the development of an mRNA-based Influenza vaccine.